✦ LIBER ✦

Low-dose regimen of interleukin-2 for metastatic renal carcinoma

✍ Scribed by Sleijfer, D.Th.; Janssen, R.A.J.; Willemse, P.H.B.; Martens, A.; De Leij, L.; De Vries, E.G.E.; Mulder, N.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The application of high-dose interleukin

✍ David F. McDermott 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

High-dose Interleukin-2 Therapy for Meta

✍ Hanzly, Michael; Aboumohamed, Ahmed; Yarlagadda, Naveen; Creighton, Terrance; Di 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 444 KB

Subcutaneous low-dose recombinant interl

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

Immunochemotherapy for Metastatic Renal

✍ Hofmockel, G.; Langer, W.; Theiss, M.; Gruss, A.; Frohmuller, H.G.W. 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 521 KB

A phase II trial of dose-intensive inter

✍ Leslie Oleksowicz; Janice P. Dutcher 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 123 KB

Clinical outcome of combined immunothera

✍ Hideaki Miyake; Toshifumi Kurahashi; Atsushi Takenaka; Taka-aki Inoue; Masato Fu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB